Avation Medical vs Abridge
Side-by-side comparison of AI visibility scores, market position, and capabilities
Avation Medical makes Vivally, the only FDA-cleared closed-loop wearable neuromodulation device for overactive bladder (OAB); raised $22M to commercialize at-home tibial nerve stimulation.
About
Avation Medical is a neuromodulation and digital health company focused on making wearable peripheral nerve stimulation accessible for patients with chronic conditions. The company''s flagship product, the Vivally System, received FDA 510(k) clearance in April 2023 for treating urinary urgency and urge urinary incontinence (UUI) caused by overactive bladder (OAB) syndrome. Vivally is the only closed-loop, non-invasive neuromodulation device cleared for at-home use for bladder control in the U.S. market.
Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.
About
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.